Shares of Molbio Diagnostics began trading at ₹980 on both the NSE and BSE, marking a 21.44% increase from the initial public offering price of ₹807. The ₹939.70 crore offering saw strong interest, with subscriptions reaching 70.27 times, primarily driven by qualified institutional buyers. The firm intends to allocate funds from the new issue toward research and development facilities and production machinery, as its Truenat platform continues to provide decentralized molecular testing services.

by shortkt.com✓

5 hours ago